AzTrials
AzTrials

Executive FunctionsNCT03639298

Executive Functions Rehabilitation in Premature Children

A study testing Intendu in people with Executive Functions, run by Vittore Buzzi Children's Hospital at 1 site in Italy.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

in more than 60% of premature children processing speed and academic failures are observed, even in children with a normal cognitive level. The aim of the study is to use for rehabilitation an application for training functional cognitive skills (Intendu®). Read more about this study

Who is it for?
Ages 4 to 6 years
Conditions the study is for
Executive Functions
What is being tested?
Intendu
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteItaly
Study dates
11 Sep 2018to 20 Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • born between 23-36.5 weeks of gestation
  • age between 4 and 0 month -6 years and 11 months
  • included in the V, Buzzi children's Hospital follow-up program
  • resident no further than 20 km from the V. Buzzi Children's Hospital
  • with WPPSI-III processing speed quotient of 91 or less

Who cannot join

  • children affected by epilepsy

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • V. Buzzi Children's Hospital

    Milan, MI, 20154

Other trials in Italy

About this study

Official title: Premature Children-executive Functions and Training With Cognitive Motion-based Videogames (Intendu®): a Rehabilitation Project

in more than 60% of premature children processing speed and academic failures are observed, even in children with a normal cognitive level.

The aim of the study is to use for rehabilitation an application for training functional cognitive skills (Intendu®). It is a software which is able to interact with the patient through a video monitoring feedback (Kinect®), enhancing brain plasticity of patients with brain dysfunction.

Read the detailed description

In Europe 6.2% of the births are born before 37 weeks of gestation. After a long period in Neonatal Intensive Care Units, the infants are dismissed but they continue to be examined in follow-up programs. It is known that advances in care have improved the rate of survival of premature newborns, but unfortunately they may have disabilities which can be severe (cerebral palsy) or mild. Mild disabilities (like attention deficit, hyperactivity, visual-perceptual and coordination disorders), even if mild, can have a significant impact on school achievements and social life. Follow-up program is dedicated to detect both severe and minor disabilities, trying to rehabilitate the children before they start formal education in school. It is well known that more than half of premature children can show impairment of processing speed and academic failures, even with normal cognitive level. Processing speed is the result of the action of different executive functions, especially working memory, planning, attention shift, inhibition and persistence.

There is growing interest over cognitive rehabilitation with video games. Recently an application for training functional cognitive skills (Intendu®) has been developed . It is a software which is able to interact with patients through a video monitoring feedback (Kinect®), enhancing brain plasticity of patients with brain dysfunction.

Aim of the study:

To evaluate whether an adaptive motion-interaction video game can improve processing speed and executive functions in premature children.

Methods:

35 children born prematurely (23-36.5 W) aged 4-6 year-old with reduced processing speed, will be invited to participate if they meet the inclusion criteria. They will be submitted to 4-5 weeks intensive training with Intendu®, (4-5 sessions per week, for a total of 20 sessions) lasting 15 minutes each, in the presence of a tutor (a psychologist expert in premature children). A control group of 35 children (no training) with the same characteristics (gestational age, cognitive profile, socio-economic status) will be available. Before and after the training/or no training the participants, in addition to the scheduled follow-up assessment, will be evaluated with two WPPSI-III®-Wechsler Preschool and Primary Scale of Intelligence subtests (Coding and Symbol search) and one Nepsy II® domain-A developmental Neuropsychological Assessment (attention and executive function). Teacher and parents evaluations will be also considered (school reports and Child Behavior Checklist - questionnaire)

Being tested
Intendu
Keywords
premature children, processing speed, executive functions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IntenduDevice

    intensive training with Motion Based Cognitive Video Games Software

Study groups in NCT03639298
Study groupRoleWhat they receive
trainingExperimentalchildren submitted to the Intendu training with motion based cognitive video games software
Receives: Device: Intendu
no trainingNo interventionchildren not submitted to the training, entering the study as a control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in WPPSI-III ( Wechsler Preschool and Primary Scale of Intelligence) Processing Speed Quotient

    the achievement of at least 10 points change of WPPSI® Processing Speed Quotient (subtests: Coding and Symbol search) will be considered significant

    Measured: assessment at baseline (time 0) and at the end of the training (after 4 weeks)

  2. change in scaled scores of Nepsy II® (developmental Neuropsychological Assessment) attention and executive function domain

    the achievement of at least 3 points change in scaled scores of Nepsy II® attention and executive function domain

    Measured: assessment at baseline (time 0) and at the end of the training (after 4 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2018
  2. Study start11 Sep 2018
  3. Primary completion19 Sep 2020
  4. Study completion20 Oct 2020

Why it stopped: Due to SARS-Cov-2 emergency we were unable to recruit the expected number of children. We will analyze the available data

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03639298
Sponsor's protocol ID
BS1
Status last verified
Mar 2021
First submitted
13 Aug 2018
Last updated
5 Apr 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: protocol of the study and patient data

Publications

  • Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009 Jan;8(1):110-24. doi: 10.1016/S1474-4422(08)70294-1.

    PubMed 19081519
  • Johnson S. Cognitive and behavioural outcomes following very preterm birth. Semin Fetal Neonatal Med. 2007 Oct;12(5):363-73. doi: 10.1016/j.siny.2007.05.004. Epub 2007 Jul 10.

    PubMed 17625996
  • Dye MW, Green CS, Bavelier D. Increasing Speed of Processing With Action Video Games. Curr Dir Psychol Sci. 2009;18(6):321-326. doi: 10.1111/j.1467-8721.2009.01660.x.

    PubMed 20485453

Questions about this trial

What is this clinical trial studying?

A study testing Intendu in people with Executive Functions, run by Vittore Buzzi Children's Hospital at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 5 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Due to SARS-Cov-2 emergency we were unable to recruit the expected number of children. We will analyze the available data). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in WPPSI-III ( Wechsler Preschool and Primary Scale of Intelligence) Processing Speed Quotient (time frame: assessment at baseline (time 0) and at the end of the training (after 4 weeks)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03639298, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in